LEUNG GABRIEL
Insider CIK 1236183 · PTX Director · AMRI Director · NVCR Director · DCTH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVCR NovoCure Ltd | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 101,109 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 89,499 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 92,444 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.31 | $17.3K | 81,229 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 83,192 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2024-06-04 | 2024-06-06 | 964 | $23.89 | $23.0K | 78,175 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2023-06-07 | 2023-06-09 | 6,277 | — | $0 | 6,277 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2023-06-07 | 2023-06-09 | 3,853 | — | $0 | 79,139 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2022-06-08 | 2022-06-10 | 4,350 | — | $0 | 4,350 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2022-06-08 | 2022-06-10 | 2,427 | — | $0 | 75,286 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-08-05 | 2021-08-06 | 1,000 | — | $0 | 2,345 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-08-05 | 2021-08-06 | 1,000 | $152.50 | $152.5K | 72,859 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-08-05 | 2021-08-06 | 1,000 | $31.45 | $31.4K | 73,859 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-07-06 | 2021-07-08 | 1,000 | — | $0 | 3,345 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-07-06 | 2021-07-08 | 1,000 | $31.45 | $31.4K | 73,859 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-07-06 | 2021-07-08 | 1,000 | $183.54 | $183.5K | 72,859 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2021-06-09 | 2021-06-11 | 1,499 | — | $0 | 1,499 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2021-06-09 | 2021-06-11 | 814 | — | $0 | 72,859 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-06-07 | 2021-06-08 | 1,000 | — | $0 | 4,345 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-06-07 | 2021-06-08 | 1,000 | $204.55 | $204.6K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-06-07 | 2021-06-08 | 1,000 | $31.45 | $31.4K | 73,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-05-05 | 2021-05-06 | 1,000 | — | $0 | 5,345 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-05-05 | 2021-05-06 | 1,000 | $31.45 | $31.4K | 73,045 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-05-05 | 2021-05-06 | 1,000 | $199.67 | $199.7K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-04-13 | 2021-04-15 | 6,000 | — | $0 | 6,345 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 2,500 | $200.00 | $500.0K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-04-13 | 2021-04-15 | 6,000 | $31.45 | $188.7K | 78,045 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 3,500 | $198.01 | $693.0K | 74,545 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-09-15 | 2020-09-16 | 7,392 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-09-15 | 2020-09-16 | 2,173 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-09-15 | 2020-09-16 | 7,392 | $100.00 | $739.2K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-09-15 | 2020-09-16 | 7,392 | $7.48 | $55.3K | 79,437 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-09-15 | 2020-09-16 | 2,173 | $100.00 | $217.3K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-09-15 | 2020-09-16 | 2,173 | $7.48 | $16.3K | 74,218 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-09-14 | 2020-09-16 | 10,000 | — | $0 | 2,173 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-09-14 | 2020-09-16 | 10,000 | $7.48 | $74.8K | 82,045 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-09-14 | 2020-09-16 | 10,000 | $95.00 | $950.0K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-09-10 | 2020-09-11 | 10,000 | — | $0 | 12,173 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-09-10 | 2020-09-11 | 10,000 | $7.48 | $74.8K | 82,045 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-09-10 | 2020-09-11 | 10,000 | $90.00 | $900.0K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-09-09 | 2020-09-11 | 9,114 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-09-09 | 2020-09-11 | 100 | $86.06 | $8.6K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-09-09 | 2020-09-11 | 9,114 | $7.03 | $64.1K | 81,159 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-09-09 | 2020-09-11 | 9,014 | $85.39 | $769.7K | 72,145 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-09-02 | 2020-09-04 | 100 | — | $0 | 9,114 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-09-02 | 2020-09-04 | 100 | $85.00 | $8.5K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-09-02 | 2020-09-04 | 100 | $7.03 | $703 | 72,145 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-08-25 | 2020-08-27 | 7,112 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-08-25 | 2020-08-27 | 7,112 | $7.03 | $50.0K | 79,157 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-08-25 | 2020-08-27 | 7,112 | $80.13 | $569.9K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-07-30 | 2020-08-03 | 7,112 | — | $0 | 7,112 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-07-30 | 2020-08-03 | 7,112 | $7.03 | $50.0K | 79,157 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-07-30 | 2020-08-03 | 7,112 | $75.00 | $533.4K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-07-22 | 2020-07-23 | 9,500 | — | $0 | 9,214 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-07-22 | 2020-07-23 | 9,500 | $7.03 | $66.8K | 81,545 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-07-22 | 2020-07-23 | 423 | $65.48 | $27.7K | 81,122 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-07-22 | 2020-07-23 | 4,573 | $66.75 | $305.2K | 76,549 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-07-22 | 2020-07-23 | 4,504 | $67.46 | $303.8K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-07-21 | 2020-07-23 | 500 | — | $0 | 18,714 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-07-21 | 2020-07-23 | 500 | $65.07 | $32.5K | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-07-21 | 2020-07-23 | 500 | $7.03 | $3.5K | 72,545 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2020-06-10 | 2020-06-12 | 5,101 | — | $0 | 5,101 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2020-06-10 | 2020-06-12 | 2,541 | — | $0 | 72,045 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-11-25 | 2019-11-26 | 20,000 | — | $0 | 19,214 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-25 | 2019-11-26 | 20,000 | $95.00 | $1.90M | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-11-25 | 2019-11-26 | 20,000 | $7.03 | $140.6K | 89,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-11-20 | 2019-11-22 | 20,000 | — | $0 | 39,214 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-11-20 | 2019-11-22 | 20,000 | $7.03 | $140.6K | 89,504 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-20 | 2019-11-22 | 20,000 | $90.00 | $1.80M | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-11-18 | 2019-11-19 | 10,000 | — | $0 | 59,214 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-11-18 | 2019-11-19 | 10,000 | $7.03 | $70.3K | 79,504 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-18 | 2019-11-19 | 10,000 | $85.00 | $850.0K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-11-15 | 2019-11-19 | 4,743 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-11-15 | 2019-11-19 | 5,257 | — | $0 | 69,214 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-11-15 | 2019-11-19 | 4,743 | $3.44 | $16.3K | 74,247 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-15 | 2019-11-19 | 354 | $84.00 | $29.7K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-15 | 2019-11-19 | 2,800 | $83.50 | $233.8K | 69,947 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-15 | 2019-11-19 | 443 | $84.02 | $37.2K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-11-15 | 2019-11-19 | 5,257 | $7.03 | $37.0K | 74,761 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-15 | 2019-11-19 | 1,700 | $82.52 | $140.3K | 73,061 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-15 | 2019-11-19 | 3,203 | $83.51 | $267.5K | 69,858 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-15 | 2019-11-19 | 1,500 | $82.55 | $123.8K | 72,747 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-11-11 | 2019-11-13 | 5,000 | — | $0 | 4,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-11 | 2019-11-13 | 5,000 | $79.57 | $397.8K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-11-11 | 2019-11-13 | 5,000 | $3.44 | $17.2K | 74,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-10-10 | 2019-10-15 | 5,000 | — | $0 | 9,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-10-10 | 2019-10-15 | 5,000 | $72.28 | $361.4K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-10-10 | 2019-10-15 | 5,000 | $3.44 | $17.2K | 74,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-09-10 | 2019-09-12 | 5,000 | — | $0 | 14,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-09-10 | 2019-09-12 | 5,000 | $76.63 | $383.1K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-09-10 | 2019-09-12 | 5,000 | $3.44 | $17.2K | 74,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-08-12 | 2019-08-14 | 5,000 | — | $0 | 19,743 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-08-12 | 2019-08-14 | 5,000 | $3.44 | $17.2K | 74,504 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-08-12 | 2019-08-14 | 5,000 | $86.45 | $432.3K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-07-10 | 2019-07-12 | 5,000 | — | $0 | 24,743 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-07-10 | 2019-07-12 | 5,000 | $3.44 | $17.2K | 74,504 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-07-10 | 2019-07-12 | 5,000 | $64.83 | $324.1K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-06-19 | 2019-06-21 | 25,000 | — | $0 | 29,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-06-19 | 2019-06-21 | 25,000 | $60.02 | $1.50M | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-06-19 | 2019-06-21 | 25,000 | $3.44 | $86.0K | 94,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-06-10 | 2019-06-12 | 5,000 | — | $0 | 54,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-06-10 | 2019-06-12 | 100 | $55.60 | $5.6K | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-06-10 | 2019-06-12 | 4,900 | $55.04 | $269.7K | 69,604 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-06-10 | 2019-06-12 | 5,000 | $3.44 | $17.2K | 74,504 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2019-05-22 | 2019-05-24 | 6,340 | — | $0 | 6,340 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2019-05-22 | 2019-05-24 | 3,359 | — | $0 | 69,504 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-05-21 | 2019-05-22 | 6,145 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-05-21 | 2019-05-22 | 6,145 | $48.87 | $300.3K | 66,145 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-05-10 | 2019-05-14 | 5,000 | — | $0 | 59,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-05-10 | 2019-05-14 | 5,000 | $49.79 | $248.9K | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-05-10 | 2019-05-14 | 5,000 | $3.44 | $17.2K | 65,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-04-10 | 2019-04-12 | 5,000 | — | $0 | 64,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-04-10 | 2019-04-12 | 5,000 | $45.95 | $229.8K | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-04-10 | 2019-04-12 | 5,000 | $3.44 | $17.2K | 65,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-03-11 | 2019-03-12 | 5,000 | — | $0 | 69,743 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-03-11 | 2019-03-12 | 5,000 | $3.44 | $17.2K | 65,000 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-03-11 | 2019-03-12 | 5,000 | $48.31 | $241.6K | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-03-01 | 2019-03-04 | 25,000 | — | $0 | 74,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-03-01 | 2019-03-04 | 25,000 | $55.01 | $1.38M | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-03-01 | 2019-03-04 | 25,000 | $3.44 | $86.0K | 85,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-02-11 | 2019-02-13 | 5,000 | — | $0 | 99,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-02-11 | 2019-02-13 | 5,000 | $49.59 | $248.0K | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-02-11 | 2019-02-13 | 5,000 | $3.44 | $17.2K | 65,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-01-25 | 2019-01-28 | 20,000 | — | $0 | 104,743 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-01-25 | 2019-01-28 | 20,000 | $3.44 | $68.8K | 80,000 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-01-25 | 2019-01-28 | 20,000 | $50.00 | $1.00M | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-01-16 | 2019-01-18 | 20,000 | — | $0 | 124,743 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-01-16 | 2019-01-18 | 20,000 | $3.44 | $68.8K | 80,000 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-01-16 | 2019-01-18 | 20,000 | $45.00 | $900.0K | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-01-10 | 2019-01-14 | 5,000 | — | $0 | 144,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-01-10 | 2019-01-14 | 5,000 | $39.91 | $199.5K | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-01-10 | 2019-01-14 | 5,000 | $3.44 | $17.2K | 65,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-01-09 | 2019-01-11 | 20,000 | — | $0 | 149,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-01-09 | 2019-01-11 | 6,726 | $40.01 | $269.1K | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-01-09 | 2019-01-11 | 20,000 | $3.44 | $68.8K | 80,000 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-01-09 | 2019-01-11 | 13,274 | $40.00 | $531.0K | 66,726 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2018-12-10 | 2018-12-12 | 5,000 | — | $0 | 169,743 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2018-12-10 | 2018-12-12 | 5,000 | $33.49 | $167.4K | 60,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2018-12-10 | 2018-12-12 | 5,000 | $3.44 | $17.2K | 65,000 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2018-05-31 | 2018-06-04 | 12,345 | — | $0 | 12,345 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2018-05-31 | 2018-06-04 | 6,145 | — | $0 | 6,145 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2018-05-22 | 2018-05-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2018-05-16 | 2018-05-17 | 100,000 | — | $0 | 174,743 | SEC↗ |
| NVCR Novocure Ltd | S Sale | 2018-05-16 | 2018-05-17 | 40,000 | $28.77 | $1.15M | 60,000 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2018-05-16 | 2018-05-17 | 100,000 | $3.44 | $344.0K | 100,000 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2018-05-15 | 2018-05-17 | 40,000 | — | $0 | 274,743 | SEC↗ |
| NVCR Novocure Ltd | S Sale | 2018-05-15 | 2018-05-17 | 40,000 | $28.88 | $1.16M | 0 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2018-05-15 | 2018-05-17 | 40,000 | $3.44 | $137.6K | 40,000 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2017-11-15 | 2017-11-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2016-11-21 | 2016-11-22 | 4,000 | — | $0 | 4,000 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award deriv | 2015-03-02 | 2015-03-04 | 6,881 | $17.05 | $117.3K | 6,881 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2015-03-02 | 2015-03-04 | 2,639 | $17.05 | $45.0K | 31,316 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award | 2014-07-07 | 2014-07-09 | 14,424 | — | $0 | 21,485 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award deriv | 2014-02-04 | 2014-02-06 | 7,201 | $10.43 | $75.1K | 7,201 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2014-02-04 | 2014-02-06 | 3,356 | $10.43 | $35.0K | 28,677 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award | 2013-11-01 | 2013-11-01 | 16,500 | — | $0 | 98,027 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award | 2013-06-05 | 2013-06-07 | 33,000 | — | $0 | 81,527 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award deriv | 2013-01-31 | 2013-02-04 | 12,367 | $5.99 | $74.1K | 12,367 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2013-01-31 | 2013-02-04 | 5,843 | $5.99 | $35.0K | 25,321 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | P Buy | 2012-06-15 | 2012-06-18 | 7,500 | $1.57 | $11.8K | 15,847 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | A Award | 2012-06-15 | 2012-06-19 | 32,680 | — | $0 | 48,527 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $2.59 | $25.9K | 10,000 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2012-06-06 | 2012-06-07 | 6,224 | $2.41 | $15.0K | 19,478 | SEC↗ |